Navigation Links
Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results
Date:4/22/2009

rthrex, Orthovita and Spectranetics) and their success in selling Kensey Nash related products in the marketplace, the impact of product recalls and other manufacturing issues, the Company's success in its research and development efforts in its cartilage repair and extracellular matrix technologies programs and competition from other technologies. For a detailed discussion of factors that could affect the Company's future operating results, please see the Company's SEC filings, including the disclosure under "Risk Factors" in those filings. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, changed circumstances or future events or for any other reason.

- FINANCIAL INFORMATION TO FOLLOW -

                                KENSEY NASH CORPORATION

                    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                      (Unaudited)

                                   Three Months             Nine Months
                                  Ended March 31,          Ended March 31,
                                 -----------------        -----------------
                                 2009         2008        2009         2008
                                 ----         ----        ----         ----
    Revenues:
        Net sales
          Biomaterial sales $12,948,185  $12,555,822  $38,717,172  $34,208,033
          Endovascular sales    947,272    1,558,049    2,616,932    4,584,230
                                -------    ---------    ---------    ---------
        Total net sales      13,895,457   14,113,871   41,334,104   38,792,263
        Royalty income        6,728,346    6,464,829   20,237,210   19,026,779
                              ---------    ---------   ----------   ----------
             Total revenues  20,623,803 
'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Kensey Nash Corporation Announces Its Third Quarter 2009 Earnings Release Date and Teleconference
2. Kensey Nash Announces 600,000 Share Stock Repurchase Program
3. Kensey Nash to Participate in the Sidoti Thirteenth Annual New York Emerging Growth Institutional Investor Forum Conference
4. Kensey Nash Announces Appointment of Chief Financial Officer
5. Kensey Nash to Present at the Canaccord Adams Musculoskeletal Conference
6. Kensey Nash Announces Director Resignation
7. Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference
8. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
9. Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2008 Earnings Release Date and Teleconference
10. Kensey Nash Provides 4th Quarter Fiscal 2008 and Fiscal Year 2009 Guidance
11. Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... 2015 , ... TransPack Toon gives users a set of 90 cartoon transitions ... transitions in 30 different styles. Presets range from snow, underwater, forest, futuristic, city and ... Toon features 90 cartoon transitions from 30 unique styles. Editors can choose between ...
(Date:9/3/2015)... ... September 03, 2015 , ... NanoCytomics LLC today announced ... company that will bring low-cost cancer pre-screening tests to primary care physicians in ... automated technology platform detects and measures cellular changes at the nanoscale level. The ...
(Date:9/3/2015)... , ... September 03, 2015 , ... William Mattar Law ... Mattar, Esq. believes this does not stop at any certain demographic or segment of ... newly produced one-minute, thirty-, fifteen- and ten-second TV commercials. , The closed captioning will ...
(Date:9/3/2015)... ... September 03, 2015 , ... The Oregon ... Academy of Integrative Health & Medicine (AIHM) Interprofessional Fellowship in Integrative Health & ... Dog, MD, an internationally renowned educator, physician and thought leader in integrative medicine. ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... agreement with Amerinet Inc., a leading national healthcare solutions organization, to provide electronic ... EMR. , Through this agreement, Amerinet members will receive negotiated pricing on E-Volve ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 3Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2
... known that hard training can lead to degradation of muscle ... to counter this but surprisingly there has to date been ... Preliminary data showing that nutritional supplements given after exercise ... provided by Ren van den Hoven and colleagues in the ...
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, Oct. ... outbreak first linked to tainted cantaloupes has risen to 25, ... 26 states, the U.S. Centers for Disease Control and Prevention ... the cantaloupes in question were recalled in mid-September, more cases ...
... Oct. 18 (HealthDay News) -- Smoking seems to have ... a life-threatening genetic disease affecting the lungs and other ... that like cystic fibrosis, smoking leads to the production ... They concluded that cystic fibrosis treatments could potentially be ...
... , TUESDAY, Oct. 18 (HealthDay News) -- Parents of children ... rather than pursue supportive end-of-life care, researchers have found. ... the health care professionals treating these very sick children under ... to alleviate their patients, discomfort, according to the report published ...
... of Minnesota has resulted in a startup that may ... blood loss or trauma. The university,s Office for Technology ... Pharmaceuticals authorizing the private company to develop and commercialize ... Duluth campuses including surgeon Gregory Beilman, biologist Matthew ...
... First results from a large-scale Phase III trial of ... of Medicine (NEJM), show the malaria vaccine candidate to ... severe malaria with an acceptable safety and tolerability profile. The ... the Bill & Melinda Gates Foundation in Seattle, Washington. ...
Cached Medicine News:Health News:Improving training efficiency in horses 2Health News:25 Deaths Now Blamed on Cantaloupe-Linked Listeria Outbreak 2Health News:Smoking's Effect on Lungs Similar to Cystic Fibrosis: Study 2Health News:Parents, Doctors Often Differ on Chemo for Incurable Kids 2Health News:Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children 2Health News:Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children 3
(Date:9/3/2015)... 2015  As part of its ongoing commitment to ... Marc R. Katz , MD, MPH, cardiac surgeon and ... Vascular Institute implanted the first HeartMate 3 left ventricular ... selected as part of the prestigious MOMENTUM 3™ Clinical ... in the United States—and the first in central Virginia—chosen ...
(Date:9/3/2015)... , Sep. 03, 2015 ... of the "Investigation Report on China,s Trastuzumab Market, ... by Genentech, trastuzumab was approved by FDA to be ... trade name of Herceptin, a major product of Roche. ... 6.56 billion around the world. After entering ...
(Date:9/3/2015)... , Sept. 3, 2015 Research and ... the "Radiology Information Systems Market by Type, Deployment ... & Forecast to 2019" report to their offering. ... is estimated at $501.1 Million 2014, and is projected ... of 7.6% from 2014 to 2019. ...
Breaking Medicine Technology:Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 3Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 4Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 3
... 8 The Health Industry Distributors Association (HIDA) announces ... key audiences about the value of medical products distribution. ... supported by medical products delivered by a distributor, yet ... supporting healthcare and making it more efficient," said Matthew ...
... 8 GlaxoSmithKline (NYSE: GSK ) today announced that ... Trademark Office (USPTO) to join the USPTO,s motion to dismiss ... Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo ... Patent and Trademark Office). GSK and the USPTO will ...
Cached Medicine Technology:GlaxoSmithKline and U.S. Patent and Trademark Office File a Motion to Dismiss Litigation Over Final Regulations 2
... Finntip Filters are ... other amplification methods, or ... aerosol contamination might occur. ... pipetting DNA/RNA solutions, infectious ...
1000 L, Racked, Pre-sterilized, 100 tips/rack Recommended for 500 and 1000 L pipettes....
... are ideal for PCR and ... any work where aerosol contamination ... for pipetting DNA/RNA solutions, infectious ... For applications requiring absolute sterility, ...
... Filters are ideal for PCR ... for any work where aerosol ... designed for pipetting DNA/RNA solutions, ... other. For applications requiring absolute ...
Medicine Products: